Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
Clear cell renal cell carcinoma (ccRCC) features metabolic dysregulation, with altered lipid metabolism and ferroptosis dysregulation driving malignancy. This review examines the interplay between lipid reprogramming and ferroptosis resistance in ccRCC pathogenesis and therapy. Tumor cells ...
Supriya Peshin: A Review of Immunotherapy in Renal Cell Carcinoma / Bicky Thapa, cancer, Nazli Dizman, OncoDaily, Oncology, Petros Grivas, Razelle Kurzrock,
Ferroptosis, a distinctive and tightly regulated form of cell death, has rapidly gained attention in the oncology community due to its potential as a therapeutic target in cancer treatment. Unlike
This clearance adds onto a previous indication for the BioTraceIO platform in liver tumor ablation.
Obesity is a well-established risk modifier for clear cell renal cell carcinoma (ccRCC), yet the molecular mechanisms underlying their ...
... clear cell renal cell carcinoma (ccRCC) remains unclear. Methods: We integrated multi-omics bioinformatics analyses from public databases (TCGA ...
The approval is supported by data from the phase 3 MK-3475A-D77 trial.
NICE's first guideline on kidney cancer recommends better use of biopsies to avoid surgery
KIM-1 emerges as a promising biomarker for renal cell carcinoma, enhancing prognosis and treatment decisions in kidney cancer management.
Ongoing studies in kidney cancer aim to explore determinants of immune-related adverse effects and strategies for mitigating them.
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.